These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 17665327)
81. Respiratory antibiotic use and clostridium difficile infection: is it the drugs or is it the doctors? Wilcox MH Thorax; 2000 Aug; 55(8):633-4. PubMed ID: 10899237 [No Abstract] [Full Text] [Related]
82. Analysis of the physicochemical interactions between Clostridium difficile toxins and cholestyramine using liquid chromatography with post-column derivatization. Palace GP; Lazari P; Norton K Biochim Biophys Acta; 2001 Mar; 1546(1):171-84. PubMed ID: 11257520 [TBL] [Abstract][Full Text] [Related]
83. Specific binding of nucleotides and NAD+ to Clostridium difficile toxin A. Lobban MD; Borriello SP FEBS Lett; 1992 Feb; 298(2-3):185-7. PubMed ID: 1544441 [TBL] [Abstract][Full Text] [Related]
84. [Evaluation of the effect of medicines on biological properties of Clostridium difficile]. Valyshev AV; Kirillov DA; Pan'kov AS; Pruss VF; Bukharin OV Zh Mikrobiol Epidemiol Immunobiol; 2003; (4):85-8. PubMed ID: 12966888 [TBL] [Abstract][Full Text] [Related]
86. Overcoming Antibiotic Resistance: Insights from Clostridium difficile and the RB Tumor Suppressor. Radulescu RT Protein Pept Lett; 2019; 26(8):553-554. PubMed ID: 31560278 [No Abstract] [Full Text] [Related]
87. Prevent the sread of Clostridium difficile. McConnell EA Nursing; 2002 Aug; 32(8):24, 26. PubMed ID: 12360910 [No Abstract] [Full Text] [Related]
88. Clostridium difficile in faecal flora after perioperative prophylaxis with ampicillin or ceftriaxone. Westh H; Iversen JT; Gyrtrup HJ J Infect; 1991 Nov; 23(3):347-50. PubMed ID: 1753154 [No Abstract] [Full Text] [Related]
89. Antibiotics in crisis. Gross M Curr Biol; 2013 Dec; 23(24):R1063-5. PubMed ID: 24501765 [No Abstract] [Full Text] [Related]
90. Prevention and treatment of Clostridium difficile infection. Gouliouris T; Brown NM; Aliyu SH Clin Med (Lond); 2011 Feb; 11(1):75-9. PubMed ID: 21404793 [No Abstract] [Full Text] [Related]
91. Pain and palliative care pharmacotherapy literature summaries and analyses. Abernethy AP J Pain Palliat Care Pharmacother; 2008; 22(2):145-51. PubMed ID: 19042839 [TBL] [Abstract][Full Text] [Related]
92. Antimicrobial resistance: The need to train clinical microbiologists. Franklin C Br Dent J; 2016 Mar; 220(5):218-9. PubMed ID: 26964574 [No Abstract] [Full Text] [Related]
93. Comparative assessment of the therapeutic drug targets of C. botulinum ATCC 3502 and C. difficile str. 630 using in silico subtractive proteomics approach. Bhardwaj T; Haque S; Somvanshi P J Cell Biochem; 2019 Sep; 120(9):16160-16184. PubMed ID: 31081164 [TBL] [Abstract][Full Text] [Related]
94. Hand hygiene and Clostridium difficile. Gay TW Ann Intern Med; 2007 Jul; 147(1):69-70. PubMed ID: 17606966 [No Abstract] [Full Text] [Related]
95. Infectious diseases 1979--antimicrobial agent-induced colitis: an update. George WL; Rolfe RD; Mulligan ME; Finegold SM J Infect Dis; 1979 Aug; 140(2):266-8. PubMed ID: 479645 [No Abstract] [Full Text] [Related]
96. Antimicrobial resistance: Antibiotics and consultant oral microbiologist posts. Pankhurst C; Rautemaa-Richardson R; Seoudi N; Smith A; Wilson M Br Dent J; 2016 Jan; 220(1):2-3. PubMed ID: 26768445 [No Abstract] [Full Text] [Related]